Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. DEVICE CLINICAL SUPPLY AGREEMENTDevice Clinical Supply Agreement • January 13th, 2015 • Bellerophon Therapeutics LLC • Pharmaceutical preparations • New Jersey
Contract Type FiledJanuary 13th, 2015 Company Industry JurisdictionThis Device Clinical Supply Agreement (this “Agreement”) is entered into as of February 9, 2014 (the “Effective Date”) by and between by and between INO Therapeutics LLC, a Delaware limited liability company, with offices at Perryville III Corporate Park, 53 Frontage Road, Third Floor, Hampton, NJ 08827 d/b/a Ikaria (“Ikaria”), and Bellerophon Pulse Technologies LLC, a Delaware limited liability company, with offices at Perryville III Corporate Park, 53 Frontage Road, Third Floor, Hampton, NJ 08827 d/b/a Ikaria (“Pulse Technologies”). Ikaria and Pulse Technologies may be individually referred to as a “Party” and together as the “Parties.”
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. DEVICE CLINICAL SUPPLY AGREEMENTDevice Clinical Supply Agreement • May 14th, 2014 • Bellerophon Therapeutics LLC • Pharmaceutical preparations • New Jersey
Contract Type FiledMay 14th, 2014 Company Industry JurisdictionThis Device Clinical Supply Agreement (this “Agreement”) is entered into as of February 9, 2014 (the “Effective Date”) by and between by and between INO Therapeutics LLC, a Delaware limited liability company, with offices at Perryville III Corporate Park, 53 Frontage Road, Third Floor, Hampton, NJ 08827 d/b/a Ikaria (“Ikaria”), and Bellerophon Pulse Technologies LLC, a Delaware limited liability company, with offices at Perryville III Corporate Park, 53 Frontage Road, Third Floor, Hampton, NJ 08827 d/b/a Ikaria (“Pulse Technologies”). Ikaria and Pulse Technologies may be individually referred to as a “Party” and together as the “Parties.”